HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Clinical trials for HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smart pillbox aims to stop patients forgetting vital cancer pills
Disease control Recruiting nowThis study is testing whether a smart pillbox, combined with text message reminders, can help people with advanced breast cancer remember to take their oral medication correctly. The goal is to see if this technology helps patients stick to their complex treatment schedule better…
Matched conditions: HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: NA • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for advanced breast cancer: experimental drug trial now recruiting
Disease control Recruiting nowThis early-stage study is testing a new experimental drug called BGB-43395, both alone and in combination with other cancer medications, for people with advanced hormone-positive breast cancer and other solid tumors. The main goals are to find safe dosage levels and see if the dr…
Matched conditions: HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug combo tested to shrink tumors before breast cancer surgery
Disease control Recruiting nowThis study is testing a newer targeted drug called trastuzumab deruxtecan, given alone or with a hormone-blocking pill (anastrozole), before surgery for early-stage breast cancer. The goal is to see which approach is better at shrinking or eliminating the tumor. It is for people …
Matched conditions: HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug trial aims to outperform standard care for Tough-to-Treat breast cancer
Disease control Recruiting nowThis study is for people with a specific, harder-to-treat type of advanced breast cancer that is hormone-sensitive but has a non-luminal genetic pattern. It will compare a newer drug called trastuzumab deruxtecan against the current standard treatment (a CDK4/6 inhibitor plus hor…
Matched conditions: HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Major trial aims to stop High-Risk breast cancer from coming back
Disease control Recruiting nowThis large, late-stage trial is testing if adding an immunotherapy drug called durvalumab to standard chemotherapy is better than chemotherapy alone for preventing cancer from returning. It is for adults with a specific high-risk type of breast cancer that is hormone-positive and…
Matched conditions: HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for seniors battling advanced breast cancer
Disease control Recruiting nowThis study is testing how well older adults tolerate a breast cancer drug called abemaciclib. It is for people aged 70 and older whose hormone-positive breast cancer has spread and worsened after previous treatments. The main goal is to understand the side effects and safety of t…
Matched conditions: HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
New hope for breast cancer patients suffering treatment side effects
Symptom relief Recruiting nowThis study is testing whether a vaginal suppository called Revaree Plus can improve vaginal health for women experiencing dryness and discomfort during breast cancer treatment. Researchers will enroll 60 women with hormone-receptor positive breast cancer who have completed primar…
Matched conditions: HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE4 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Mar 27, 2026 12:41 UTC
-
Needles vs. pressure: new hope for black women battling breast cancer drug pain
Symptom relief Recruiting nowThis study is testing whether acupuncture or virtual acupressure can prevent severe joint pain caused by a common breast cancer medication. It focuses on Non-Hispanic Black postmenopausal women with early-stage breast cancer, as they are more likely to experience this side effect…
Matched conditions: HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Mar 11, 2026 14:53 UTC
-
Scientists track sleep patterns in breast cancer patients to uncover hidden health links
Knowledge-focused Recruiting nowThis study aims to understand how breast cancer treatment affects sleep patterns and quality. Researchers will follow 100 patients with early-stage breast cancer, having them wear sleep trackers and complete surveys from treatment through recovery. The goal is to identify factors…
Matched conditions: HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC
-
Scientists build a living library of cancer to unlock treatment secrets
Knowledge-focused Recruiting nowThis study is collecting tissue and blood samples from cancer patients over time to create a research resource called a biobank. Researchers will analyze these samples to understand how cancer changes during treatment and why some treatments stop working. The goal is to help scie…
Matched conditions: HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:09 UTC